Eick Angelia A, Hu Zheng, Wang Zhong, Nevin Remington L
Army Medical Surveillance Activity, US Army Center for Health Promotion and Preventive Medicine, Silver Spring, MD 20910, USA.
Vaccine. 2008 Jan 24;26(4):494-501. doi: 10.1016/j.vaccine.2007.11.035. Epub 2007 Dec 4.
Recent mumps outbreaks have evoked concerns of decreasing mumps immunity among adolescents and adults, including US military recruits subject to differing mumps immunization policies. To compare mumps incidence and to assess initial measles, mumps and rubella seropositivity, we conducted a cohort study among recruits from 2000 to 2004. Mumps incidence in the targeted MMR and universal MMR cohorts was 4.1 and 3.5 per 100,000 person-years, respectively, giving an incidence rate ratio of 1.16 (P=0.67). Measles, mumps, and rubella seropositivity was 84.6%, 89.5%, and 93.2%, respectively. Among recruits with measles and rubella immunity, 92.8% were mumps immune. These findings support the policy of targeting MMR immunization based upon measles and rubella serology alone.
近期的腮腺炎疫情引发了人们对青少年和成年人腮腺炎免疫力下降的担忧,其中包括美国军事新兵,他们遵循不同的腮腺炎免疫政策。为了比较腮腺炎发病率并评估初始麻疹、腮腺炎和风疹血清阳性率,我们在2000年至2004年期间对新兵进行了一项队列研究。目标MMR队列和通用MMR队列中的腮腺炎发病率分别为每10万人年4.1例和3.5例,发病率比为1.16(P = 0.67)。麻疹、腮腺炎和风疹血清阳性率分别为84.6%、89.5%和93.2%。在具有麻疹和风疹免疫力的新兵中,92.8%具有腮腺炎免疫力。这些发现支持仅基于麻疹和风疹血清学进行MMR免疫接种的政策。